ArticlePharmaceutics2022

Design of a Transdermal Sustained Release Formulation Based on Water-Soluble Ointment Incorporating Tulobuterol Nanoparticles.

Noriaki Nagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.